Answers are grounded in this paper and cite their sources.
Chitosan nanoparticles are a promising candidate for therapeutic intervention against Alzheimer's disease. They inhibit amyloid aggregation and dissolve preformed fibrils.
No takes yet. Share an insight, caveat, or question.
Jha et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: